Literature DB >> 10217354

Lysophosphatidylcholine activates mitogen-activated protein kinases by a tyrosine kinase-dependent pathway in bovine aortic endothelial cells.

H Ozaki1, K Ishii, H Arai, N Kume, T Kita.   

Abstract

Lysophosphatidylcholine (lyso-PC) is a major component of an atherogenic lipoprotein. In this study, to investigate the involvement of mitogen-activated protein kinases in the signaling pathway by lyso-PC in endothelial cells, we measured the activity of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in bovine aortic endothelial cells. Lyso-PC activated ERK and JNK in a dose-dependent manner. However, the time courses of activation of these kinases were different. ERK and JNK activation by lyso-PC was inhibited by a tyrosine kinase inhibitor, herbimycin A, but not by a protein kinase C (PKC) specific inhibitor. We conclude, therefore, that lyso-PC-mediated ERK and JNK activation is caused by a tyrosine kinase-dependent mechanism, but not conventional types of PKC-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217354     DOI: 10.1016/s0021-9150(98)00297-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

Review 1.  Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.

Authors:  Robert S Rosenson; Diana M Stafforini
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

2.  Mechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aorta.

Authors:  T Matsumoto; T Kobayashi; K Kamata
Journal:  Br J Pharmacol       Date:  2006-10-09       Impact factor: 8.739

3.  Lysophosphatidylcholine potentiates vascular contractile responses in rat aorta via activation of tyrosine kinase.

Authors:  Hiroshi Suenaga; Katsuo Kamata
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

4.  Impact of lysophosphatidylcholine on survival and function of UEA-1(+)acLDL (+) endothelial progenitor cells in patients with coronary artery disease.

Authors:  Seong Hun Hong; Hyun Hee Jang; So Ra Lee; Kyung Hye Lee; Jong Shin Woo; Jin Bae Kim; Woo-Shik Kim; Byung Il Min; Ki Ho Cho; Kwon Sam Kim; Xianwu Cheng; Weon Kim
Journal:  Heart Vessels       Date:  2014-02-09       Impact factor: 2.037

5.  Lysophosphatidylcholine exhibits selective cytotoxicity, accompanied by ROS formation, in RAW 264.7 macrophages.

Authors:  Cheon Ho Park; Mee Ree Kim; Jong-Min Han; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2009-02-28       Impact factor: 1.880

6.  A 3D disease and regeneration model of peripheral nervous system-on-a-chip.

Authors:  Sujin Hyung; Seung-Ryeol Lee; Jiho Kim; Youngtaek Kim; Suryong Kim; Hong Nam Kim; Noo Li Jeon
Journal:  Sci Adv       Date:  2021-01-29       Impact factor: 14.136

7.  Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathway.

Authors:  Feiyue Xing; Jing Liu; Yongyan Mo; Zhifeng Liu; Qinghe Qin; Jingzhen Wang; Zhenhua Fan; Yutian Long; Na Liu; Kesen Zhao; Yong Jiang
Journal:  J Cell Mol Med       Date:  2008-06-20       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.